Perinatal mortality · Pregnant women considered to have periodontal disease (gingivitis or periodontitis) after dental examination
It is very uncertain whether periodontal treatment (scaling and root planing, alone or with… changes perinatal mortality (including fetal and neonatal deaths up to the… compared with alternative (less intensive) periodontal treatment, alone or with… (very low certainty).
1 finding from 1 review
Patient response: moderate or severe pain at 1 day postoperative · People with maxillary palatally displaced (impacted) canines, unilateral or bilateral (children/adolescents; mean ages 14.2 to 17.5 years)
Open surgical exposure showed no clear difference in patient response: moderate or severe pain at 1 day postoperative compared with closed surgical exposure; GRADE not reported.
1 finding from 1 review
Interruptions to cancer treatment (unscheduled radiotherapy breaks of 5 or more days) · Adults with cancer receiving treatment
Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in interruptions to cancer treatment (unscheduled radiotherapy breaks… compared with placebo; GRADE not reported.
1 finding from 1 review
Death from all causes during treatment (range 6 days to 16 days) · acute ischaemic stroke
Low‐molecular‐weight heparins or heparinoids showed no clear difference in death from all causes during treatment (range 6 days to 16 days) compared with unfractionated heparin (low certainty).
1 finding from 1 review
Deep vein thrombosis · acute ischaemic stroke
Low‐molecular‐weight heparins or heparinoids may leads to lower deep vein thrombosis during treatment period (range 6 days to 16 days) compared with unfractionated heparin (low certainty).
1 finding from 1 review
Pulmonary embolism · acute ischaemic stroke
Low‐molecular‐weight heparins or heparinoids showed no clear difference in pulmonary embolism during treatment period (range 6 days to 16 days) compared with unfractionated heparin (low certainty).
1 finding from 1 review
Symptomatic intracranial haemorrhage/haemorrhagic transformation of the cerebral infarct during treatment period (range 6 days to 16 days)⁹ · acute ischaemic stroke
Low‐molecular‐weight heparins or heparinoids showed no clear difference in symptomatic intracranial haemorrhage/haemorrhagic transformation of… compared with unfractionated heparin (low certainty).
1 finding from 1 review
Death or dependency · people with acute stroke
Glyceryl trinitrate (GTN) showed no clear difference in death or dependency (mRS>2), end of trial (90 days) compared with no GTN (high certainty).
1 finding from 1 review
Death by end of trial · people with acute stroke
Glyceryl trinitrate (GTN) showed no clear difference in death, end of trial (90 days) compared with no GTN (high certainty).
1 finding from 1 review
Quality of life, end of trial (90 days) · people with acute stroke
1 finding from 1 review
Adverse effects: headache · people with acute stroke
Glyceryl trinitrate (GTN) leads to higher adverse event: Headache, on treatment (7‐12 days) compared with no GTN (high certainty).
1 finding from 1 review
Intervention not reported
Change in total calories (Kcal/day): at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Intervention not reported
Change in total protein (g/day): at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Intervention not reported
Change in total fat (g/day): at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Intervention not reported
Length of initial hospital stay (days) · people with stroke
The intervention probably leads to higher length of initial hospital stay (days) (moderate certainty).
1 finding from 1 review
Mortality before hospital discharge · respiratory failure in preterm infants
Inhaled NO showed no clear difference in death before discharge ‐ Studies with entry before 3 days based on… compared with control (high certainty).
2 findings from 1 review
Neurodevelopmental disability · respiratory failure in preterm infants
Inhaled NO showed no clear difference in neurodevelopmental disability ‐ Studies with entry after 3 days… compared with control (moderate certainty).
2 findings from 1 review
Death or bronchopulmonary dysplasia · respiratory failure in preterm infants
Inhaled NO showed no clear difference in death or bronchopulmonary dysplasia at 36 weeks ‐ Studies with entry… compared with control (high certainty).
1 finding from 1 review
Death or bronchopulmonary dysplasia at 36 weeks PMA · respiratory failure in preterm infants
Inhaled NO showed no clear difference in death or bronchopulmonary dysplasia at 36 weeks ‐ Studies with entry… compared with control (high certainty).
1 finding from 1 review
Intraventricular haemorrhage, Papile grade 3/4 · respiratory failure in preterm infants
Inhaled NO showed no clear difference in intraventricular haemorrhage (grade 3 or 4) ‐ Studies with entry… compared with control (high certainty).
1 finding from 1 review